Stormy Weather: Navigating Profitability in the NFP Hospital Space with Kevin Holloran

Hospitals had a rough 2022 as they faced higher labor and supply costs, volatile patient volumes, and fragile payer relations. More than half of hospitals in 2022 are expected to result in negative margins, according to Kaufman Hall. Kevin Holloran, Senior Director at Fitch Ratings, said 2022 was “one of the worst years ever in healthcare,” and he projected hospitals would face a bumpy 2023.

On this episode of Healthcare Rethink, Jonathan Wiik, VP of Health Insights at FinThrive and Kevin Holloran dig deeper into financial performance for health systems and hospitals.

Topics covered:

  • Headwinds affecting the not-for-profit hospital sector and what is driving those headwinds
  • Advice for CFOs and recommendation to insulate operations and profitability
  • Thoughts on M&A activity
  • How the future of payer/provider collaboration may look
  • Issues affecting profitability from labor to patient volumes and possible impact from recent legislation

Recent Episodes

As hospitals look to improve outcomes with faster, more informed decisions, infrastructure limitations remain a major hurdle. This episode—part two of a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring—dives into what’s holding back smarter, more connected care. Intel’s Andrew Lamkin, AI Solutions Architect, and Bikram Day,…

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…